We are live on ! Find out more
Ensign Peak Advisors

Ensign Peak Advisors Portfolio holdings

AUM $53.7B
1-Year Est. Return 29.47%
This Fund
S&P 500
This Quarter Est. Return
-2.86%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
AUM
$49.2B
AUM Growth
-$3.11B
Cap. Flow
-$91.1M
Cap. Flow %
-0.19%
Top 10 Hldgs %
25.77%
Holding
2,288
New
88
Increased
463
Reduced
591
Closed
79

Sector Composition

Rank Sector Weight
1 Technology 22.61%
2 Healthcare 15.91%
3 Financials 13.97%
4 Consumer Discretionary 9.85%
5 Industrials 7.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACCD
2176
DELISTED
Accolade Inc
ACCD
$21K ﹤0.01%
1,170
IMVT icon
2177
Immunovant
IMVT
$7.99B
$20K ﹤0.01%
3,680
ARVL
2178
DELISTED
Arrival Ordinary Shares
ARVL
$20K ﹤0.01%
110
-8
-7% -$1.72K
DNUT icon
2179
Krispy Kreme
DNUT
$564M
$19K ﹤0.01%
+1,310
New +$19.7K
CCRN
2180
DELISTED
Cross Country Healthcare
CCRN
$17K ﹤0.01%
+790
New +$17.1K
TMCI icon
2181
Treace Medical Concepts
TMCI
$260M
$17K ﹤0.01%
+900
New +$17.5K
ORMP icon
2182
Oramed Pharmaceuticals
ORMP
$171M
$15K ﹤0.01%
+1,760
New +$18K
DNA.WS
2183
DELISTED
Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share
DNA.WS
$14K ﹤0.01%
16,100
QTTB icon
2184
Q32 Bio
QTTB
$467M
$13K ﹤0.01%
231
AMTI
2185
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
$11K ﹤0.01%
1,430
RLMD icon
2186
Relmada Therapeutics
RLMD
$549M
$10K ﹤0.01%
360
DRVN icon
2187
Driven Brands
DRVN
$2.47B
$9K ﹤0.01%
+340
New +$9.84K
TSHA icon
2188
Taysha Gene Therapies
TSHA
$1.57B
$9K ﹤0.01%
1,410
ICVX
2189
DELISTED
Icosavax, Inc. Common Stock
ICVX
$9K ﹤0.01%
+1,340
New +$21.1K
SGFY
2190
DELISTED
Signify Health, Inc.
SGFY
$9K ﹤0.01%
480
HEI icon
2191
HEICO Corp
HEI
$50.8B
$8K ﹤0.01%
50
-4,570
-99% -$663K
LEG icon
2192
Leggett & Platt
LEG
$1.47B
$8K ﹤0.01%
220
GRPN icon
2193
Groupon
GRPN
$1.07B
$7K ﹤0.01%
+370
New +$8.23K
INMD icon
2194
InMode
INMD
$889M
$7K ﹤0.01%
+200
New +$8.96K
PMVP icon
2195
PMV Pharmaceuticals
PMVP
$58.7M
$7K ﹤0.01%
340
MODN
2196
DELISTED
MODEL N, INC.
MODN
$7K ﹤0.01%
+260
New +$6.78K
HAYW icon
2197
Hayward Holdings
HAYW
$3.28B
$5K ﹤0.01%
+320
New +$6.05K
MX icon
2198
Magnachip Semiconductor
MX
$118M
$5K ﹤0.01%
+270
New +$4.85K
NOMD icon
2199
Nomad Foods
NOMD
$1.7B
$5K ﹤0.01%
233
-11,189
-98% -$272K
PRTS icon
2200
CarParts.com
PRTS
$42.4M
$5K ﹤0.01%
75

Similar funds

Ensign Peak Advisors's Q1 2022 Portfolio in Review

As of Q1 2022, Ensign Peak Advisors held 2,288 positions worth $49.2B, down 5.9% from $52.3B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Ensign Peak Advisors's Q1 2022 filing shows 88 new, 463 increased, 591 reduced and 79 closed positions. Its largest new stake was Constellation Energy: 260,204 shares worth $14.6M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $105M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.

  • Ensign Peak Advisors's largest Q1 2022 buy was Constellation Energy: 260,204 shares worth $14.6M.
  • Ensign Peak Advisors added most to iShares Russell 2000 ETF in Q1 2022, an estimated $261M increase.
  • Ensign Peak Advisors's biggest Q1 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $105M.
  • Ensign Peak Advisors fully exited Athene Holding Ltd. Class A Common Shares in Q1 2022, selling an estimated $64.3M.
  • Ensign Peak Advisors's ten largest holdings make up 26% of its $49.2B portfolio in Q1 2022.
  • Ensign Peak Advisors opened 88 new positions and closed 79 in Q1 2022.
  • Ensign Peak Advisors's portfolio value fell 5.9% quarter-over-quarter to $49.2B.

Based on Ensign Peak Advisors's 13F filing for Q1 2022, filed 16 May 2022.